farglitazar has been researched along with ciglitazone in 1 studies
| Studies (farglitazar) | Trials (farglitazar) | Recent Studies (post-2010) (farglitazar) | Studies (ciglitazone) | Trials (ciglitazone) | Recent Studies (post-2010) (ciglitazone) |
|---|---|---|---|---|---|
| 35 | 3 | 5 | 473 | 0 | 77 |
| Protein | Taxonomy | farglitazar (IC50) | ciglitazone (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 4.655 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.086 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.22 | |
| Adenosine receptor A3 | Homo sapiens (human) | 3.047 | |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Homo sapiens (human) | 2.7 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.22 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.225 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Henke, BR; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Orband-Miller, LA; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM | 1 |
1 other study(ies) available for farglitazar and ciglitazone
| Article | Year |
|---|---|
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
Topics: Administration, Oral; Aminopyridines; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Lipids; Male; Mice; Oxazoles; Propionates; Radioligand Assay; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Stereoisomerism; Structure-Activity Relationship; Transcription Factors; Transfection; Tyrosine | 1998 |